Index of reports
> Death (38)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 38 Next >>
Possible Depakene side effects in 34 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27
Patient: 34 year old male
Reactions: Intestinal Ischaemia, Ileus, Gastrointestinal Necrosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
End date: 2012-06-25
Lepticur
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-05
End date: 2012-06-25
Loxapine HCL
Dosage: 275 drops daily
Administration route: Oral
Indication: Aggression
Start date: 2012-06-14
End date: 2012-06-25
Quetiapine
Dosage: daily
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2012-06-05
End date: 2012-06-25
Valium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
End date: 2012-06-25
Possible Depakene side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Multi-Organ Failure, Diarrhoea, Acute Respiratory Distress Syndrome, Hepatorenal Failure, Drug Rash With Eosinophilia and Systemic Symptoms, Convulsion, Disease Progression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2006-11-11
End date: 2009-09-07
Phenytoin Sodium CAP
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Tegretol
Administration route: Oral
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2010-06-11
End date: 2010-10-05
Temodal
Administration route: Oral
Start date: 2008-02-21
End date: 2008-02-25
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2009-09-28
End date: 2010-05-04
Temodal
Administration route: Oral
Start date: 2007-11-29
End date: 2007-12-03
Temodal
Administration route: Oral
Start date: 2008-04-17
End date: 2008-04-21
Temodal
Administration route: Oral
Start date: 2008-10-02
End date: 2008-10-06
Temodal
Administration route: Oral
Start date: 2008-10-30
End date: 2008-11-03
Temodal
Administration route: Oral
Start date: 2010-02-08
End date: 2010-02-12
Temodal
Administration route: Oral
Start date: 2010-03-08
End date: 2010-03-12
Temodal
Administration route: Oral
Start date: 2010-06-11
End date: 2010-06-15
Temodal
Dosage: 150 mg/m2, qd
Administration route: Oral
Start date: 2007-01-25
End date: 2009-05-18
Temodal
Administration route: Oral
Start date: 2007-03-22
End date: 2007-03-26
Temodal
Administration route: Oral
Start date: 2007-06-14
End date: 2007-06-18
Temodal
Administration route: Oral
Start date: 2007-08-09
End date: 2007-08-13
Temodal
Administration route: Oral
Start date: 2007-10-04
End date: 2007-10-08
Temodal
Administration route: Oral
Start date: 2009-12-14
End date: 2009-12-18
Temodal
Administration route: Oral
Start date: 2008-05-15
End date: 2008-05-19
Temodal
Administration route: Oral
Start date: 2009-10-26
End date: 2009-10-30
Temodal
Dosage: 75 mg/m2, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-11-28
End date: 2006-12-26
Temodal
Administration route: Oral
Start date: 2007-02-22
End date: 2007-02-26
Temodal
Administration route: Oral
Start date: 2007-11-01
End date: 2007-11-05
Temodal
Administration route: Oral
Start date: 2008-03-20
End date: 2008-03-24
Temodal
Administration route: Oral
Start date: 2008-07-10
End date: 2008-07-14
Temodal
Administration route: Oral
Start date: 2009-01-22
End date: 2009-01-26
Temodal
Administration route: Oral
Start date: 2009-04-16
End date: 2009-04-20
Temodal
Administration route: Oral
Start date: 2010-01-11
End date: 2010-01-15
Temodal
Administration route: Oral
Start date: 2010-07-09
End date: 2010-07-13
Temodal
Administration route: Oral
Start date: 2010-09-03
End date: 2010-09-07
Temodal
Administration route: Oral
Start date: 2007-01-25
End date: 2007-01-29
Temodal
Administration route: Oral
Start date: 2007-09-06
End date: 2007-09-10
Temodal
Administration route: Oral
Start date: 2007-12-27
End date: 2007-12-31
Temodal
Administration route: Oral
Start date: 2008-01-24
End date: 2008-01-28
Temodal
Administration route: Oral
Start date: 2008-08-07
End date: 2008-08-11
Temodal
Administration route: Oral
Start date: 2009-03-19
End date: 2009-03-23
Temodal
Administration route: Oral
Start date: 2010-05-03
End date: 2010-05-04
Temodal
Administration route: Oral
Start date: 2007-04-19
End date: 2007-04-23
Temodal
Administration route: Oral
Start date: 2007-05-17
End date: 2007-05-21
Temodal
Administration route: Oral
Start date: 2007-07-12
End date: 2007-07-16
Temodal
Administration route: Oral
Start date: 2008-09-04
End date: 2008-09-08
Temodal
Administration route: Oral
Start date: 2008-11-28
End date: 2008-12-02
Temodal
Administration route: Oral
Start date: 2008-12-25
End date: 2008-12-29
Temodal
Administration route: Oral
Start date: 2009-02-19
End date: 2009-02-23
Temodal
Administration route: Oral
Start date: 2009-05-14
End date: 2009-05-18
Temodal
Administration route: Oral
Start date: 2009-09-28
End date: 2009-10-02
Temodal
Administration route: Oral
Start date: 2010-04-05
End date: 2010-04-09
Temodal
Administration route: Oral
Start date: 2008-06-12
End date: 2008-06-16
Temodal
Administration route: Oral
Start date: 2010-08-06
End date: 2010-08-10
Temodal
Administration route: Oral
Start date: 2010-10-01
End date: 2010-10-05
Other drugs received by patient: Depakene; Phenobarbital TAB; Betamethasone Sodium Phosphate; Kytril; Zonisamide; Diprivan; Isozol; Topiramate; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec
Possible Depakene side effects in 34 year old male
Reported by a physician from France on 2012-08-22
Patient: 34 year old male
Reactions: Intestinal Ischaemia, Gastrointestinal Necrosis, Intestinal Obstruction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-06-25
Lepticur
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-05
End date: 2012-06-25
Loxapine HCL
Administration route: Oral
Indication: Aggression
Start date: 2012-06-14
End date: 2012-06-25
Quetiapine Fumarate
Dosage: drug reported as xeroquel
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2012-06-05
End date: 2012-06-25
Valium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-06-25
Possible Depakene side effects in 75 year old male
Reported by a physician from Japan on 2012-08-07
Patient: 75 year old male
Reactions: Thrombocytopenia, Cerebrovascular Accident
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Dosage: daily dose: 2 g
Administration route: Oral
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-15
End date: 2011-10-20
Lamictal
Dosage: daily dose: 100 mg
Administration route: Oral
Possible Depakene side effects in 75 year old male
Reported by a physician from Japan on 2012-08-07
Patient: 75 year old male
Reactions: Cerebrovascular Accident, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Dosage: daily dose: 2 g
Administration route: Oral
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-15
End date: 2011-10-20
Lamictal
Dosage: daily dose: 100 mg
Administration route: Oral
Possible Depakene side effects in 16 year old female
Reported by a health professional (non-physician/pharmacist) from Cameroon on 2012-08-06
Patient: 16 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20
Patient: female
Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy, Congenital Teratoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Clobazam
Dosage: 5 mg in the morning and 10 mg in the evening
Start date: 2009-02-01
End date: 2009-03-01
Clobazam
Start date: 2009-03-01
End date: 2009-03-31
Clobazam
End date: 2009-02-01
Depakene
End date: 2009-03-31
Keppra
End date: 2009-03-01
Keppra
Start date: 2009-03-01
End date: 2009-03-31
Possible Depakene side effects in 54 year old female
Reported by a physician from China on 2012-06-12
Patient: 54 year old female
Reactions: Drug Interaction, Status Epilepticus
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient possibly interacting with the suspect drug: Phenobarbital TAB
Administration route: Oral
Indication: Epilepsy
Phenobarbital TAB
Administration route: Oral
Start date: 2012-05-20
End date: 2012-05-22
Sodium Bromide
Administration route: Oral
Indication: Epilepsy
Sodium Bromide
Administration route: Oral
Start date: 2012-05-20
End date: 2012-05-22
Possible Depakene side effects in 54 year old female
Reported by a consumer/non-health professional from China on 2012-06-08
Patient: 54 year old female
Reactions: Drug Interaction, Status Epilepticus
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient possibly interacting with the suspect drug: Phenobarbital TAB
Administration route: Oral
Indication: Epilepsy
Phenobarbital TAB
Administration route: Oral
Start date: 2012-05-20
End date: 2012-05-22
Sodium Bromide
Administration route: Oral
Start date: 2012-05-20
End date: 2012-05-22
Sodium Bromide
Administration route: Oral
Indication: Epilepsy
Possible Depakene side effects in
Reported by a consumer/non-health professional from Brazil on 2012-06-04
Patient:
Reactions: Ultrasound Scan Abnormal, Dandy-Walker Syndrome, Foetal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in
Reported by a consumer/non-health professional from Brazil on 2012-06-01
Patient:
Reactions: Dandy-Walker Syndrome, Foetal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-01
Patient:
Reactions: Foetal Anticonvulsant Syndrome, Congenital Hand Malformation, Foetal Exposure During Pregnancy, Exomphalos, Limb Malformation, Neck Deformity, Talipes, Abortion Induced, Foetal Malformation
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in 42 year old male
Reported by a physician from Japan on 2012-04-18
Patient: 42 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Glioblastoma Multiforme, Hepatorenal Failure, Neoplasm Progression, Status Epilepticus, Drug Rash With Eosinophilia and Systemic Symptoms, Multi-Organ Failure, Diarrhoea, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Depakene
Dosage: po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-11-11
End date: 2009-09-07
Phenytoin
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Tegretol
Dosage: po
Administration route: Oral
Indication: Status Epilepticus
Start date: 2009-06-25
End date: 2009-09-07
Temodal
Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2009-09-28
End date: 2010-05-04
Temodal
Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2010-06-11
End date: 2010-10-05
Temodal
Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-01-25
End date: 2009-05-18
Temodal
Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-11-28
End date: 2006-12-26
Other drugs received by patient: Kytril / 01178102 /; Zonisamide; Isozol; Topina (Topiramate); Phenobarbital TAB; Diprivan; Biofermin (Lactomin)
Possible Depakene side effects in 70 year old male
Reported by a physician from Japan on 2012-04-05
Patient: 70 year old male
Reactions: Death, Pancytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-07
End date: 2011-12-13
Keppra
Dosage: 1000mg per day
Administration route: Oral
Indication: Convulsion
Start date: 2011-12-07
End date: 2011-12-18
Lamictal
Administration route: Oral
Start date: 2011-12-28
End date: 2012-02-13
Lamictal
Dosage: 50mg per day
Administration route: Oral
Indication: Epilepsy
Start date: 2011-12-18
End date: 2011-12-27
Temodal
Indication: Brain Neoplasm
Possible Depakene side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-03-28
Patient: 30 year old female, weighing 63.0 kg (138.6 pounds)
Reactions: Death, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clozaril
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2000-12-28
End date: 2012-02-05
Depakene
Dosage: 1 at bedtime
Administration route: Oral
Indication: Affective Disorder
Start date: 2003-11-19
End date: 2012-02-05
Depakene
Indication: Affective Disorder
Other drugs received by patient: Gemfibrozil; Sennapur; Halin; Magnesium Oxide
Possible Depakene side effects in
Reported by a physician from Egypt on 2012-03-23
Patient:
Reactions: Caesarean Section, Haemorrhage, Foetal Exposure During Pregnancy, Sepsis, Hypoxia, Encephalitic Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in
Reported by a physician from France on 2012-03-08
Patient:
Reactions: Spina Bifida, Foetal Exposure During Pregnancy, Abortion Induced
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Possible Depakene side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-03-01
Patient: 30 year old female
Reactions: Death, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clozaril
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2000-12-28
End date: 2012-02-05
Depakene
Administration route: Oral
Indication: Affective Disorder
Start date: 2003-11-19
End date: 2012-02-05
Other drugs received by patient: Gemfibrozil; Halin; Magnesium Oxide; Sennapur
Possible Depakene side effects in
Reported by a pharmacist from Taiwan, Province of China on 2012-02-29
Patient:
Reactions: Abdominal Pain, Gastrointestinal Motility Disorder, Dyspnoea, Urinary Tract Infection, Ileus, Heart Rate Increased, Sepsis, Liver Function Test Abnormal, Tenderness, Blood Pressure Decreased, White Blood Cell Count Increased, Blood Glucose Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Clozaril
Dosage: 100mg/pill, range from 25mg to 1200mg
Indication: Mental Disorder
Start date: 2000-12-28
End date: 2012-02-05
Depakene
Dosage: dose:200mg/pill, 500mg/pill, (range from 200mg to 2400mg)
Indication: Mental Disorder
Start date: 2003-11-19
End date: 2012-02-05
Other drugs received by patient: Haloperidol
Possible Depakene side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-02-17
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Confusional State, Pneumonia, Diabetic Complication, Secretion Discharge, Somnolence, Speech Disorder, Blood Glucose Decreased, Eyelid Function Disorder, Tongue Disorder
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Diazepam; Captopril; Haloperidol; Nortriptyline HCL; Insulin
Possible Depakene side effects in male
Reported by a pharmacist from Japan on 2012-02-15
Patient: male, weighing 64.6 kg (142.1 pounds)
Reactions: Nervous System Disorder, Disorientation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 200 mg, bid
Administration route: Oral
Indication: Epilepsy
Start date: 2007-10-01
End date: 2011-11-20
Fentanyl-100
Dosage: 0.4 mg, qod
Start date: 2011-11-15
End date: 2011-11-16
Fentanyl-100
Dosage: 0.2 mg, qod
Start date: 2011-11-14
End date: 2011-11-14
Fentanyl-100
Dosage: 0.1 mg, qod
Indication: Pain
Start date: 2011-11-12
End date: 2011-11-13
Fentanyl-100
Dosage: unk
Start date: 2011-11-17
End date: 2011-11-23
Prograf
Dosage: 0.155 mg, uid/qd
Start date: 2011-11-14
End date: 2011-11-20
Prograf
Dosage: 0.31 mg, uid/qd
Indication: Prophylaxis Against Graft Versus Host Disease
Start date: 2011-11-10
End date: 2011-11-13
Prograf
Dosage: unk
Start date: 2011-11-21
End date: 2011-11-23
Other drugs received by patient: Famotidine; Funguard; Methotrexate; Vitamedin; Ubiron; Ceftazidime; Filgrastim; Pantosin; Pentazocine Lactate; Acyclovir; Glycyron; Lendormin; Magmitt; Teicoplanin
Possible Depakene side effects in 18 year old male
Reported by a consumer/non-health professional from Italy on 2012-01-30
Patient: 18 year old male, weighing 100.0 kg (220.0 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Depakene
Dosage: 6 dosage form; daily
Administration route: Oral
Indication: Epilepsy
Frisium
Dosage: 3 dosage form: daily
Administration route: Oral
Indication: Epilepsy
Possible Depakene side effects in 85 year old male
Reported by a physician from Poland on 2012-01-13
Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Death, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abilify
Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Depakene
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Lamotrigine
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Possible Depakene side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: 17 year old female
Reactions: Multi-Organ Failure, Agranulocytosis, Histiocytosis Haematophagic, Condition Aggravated, Pancytopenia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amikacin
Dosage: unk
Indication: Escherichia Bacteraemia
Start date: 2008-12-25
Cyclophosphamide
Dosage: 750.0 mg, 1x/cyc
Indication: Sjogren's Syndrome
Start date: 2008-12-25
Depakene
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-26
Diprivan
Dosage: unk
Indication: Sedation
Start date: 2008-12-18
Fosphenytoin Sodium
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-09
End date: 2008-12-01
Keppra
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-06
Pantoprazole Sodium
Dosage: unk
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-12-01
Pentothal
Dosage: unk
Indication: Sedation
Start date: 2008-12-08
Phenobarbital TAB
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-01
Piperacillin and Tazobactam
Dosage: unk
Indication: Escherichia Bacteraemia
Start date: 2008-12-25
Sufenta Preservative Free
Dosage: unk
Indication: Sedation
Start date: 2008-11-29
End date: 2008-12-25
Urbanyl
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-15
Vancomycin HCL
Dosage: unk
Indication: Pneumonia Staphylococcal
Start date: 2008-12-01
Other drugs received by patient: Paracetamol; Neostigmine; Duphalac; Solu-Medrol; Norepinephrine; Neupogen
Possible Depakene side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: 17 year old female
Reactions: Multi-Organ Failure, Histiocytosis Haematophagic, Agranulocytosis, Pancytopenia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amikacin
Dosage: unk
Indication: Escherichia Infection
Start date: 2008-12-25
Cyclophosphamide
Dosage: 750 mg
Indication: Sjogren's Syndrome
Start date: 2008-12-11
Depakene
Dosage: unk
Indication: Epilepsy
Start date: 2008-12-26
Diprivan
Dosage: unk
Indication: Sedation
Start date: 2008-12-18
Fosphenytoin Sodium
Dosage: 750 mg, cyclic
Indication: Epilepsy
Start date: 2008-12-11
End date: 2008-12-01
Keppra
Dosage: unk
Indication: Epilepsy
Start date: 2008-12-06
Pantoprazole Sodium
Dosage: unk
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-12-01
Pentothal
Dosage: unk
Indication: Sedation
Start date: 2008-12-08
Phenobarbital TAB
Dosage: unk
Indication: Epilepsy
Start date: 2008-12-01
Piperacillin and Tazobactam
Dosage: unk
Indication: Escherichia Infection
Start date: 2008-12-25
Sufenta Preservative Free
Dosage: unk
Indication: Sedation
Start date: 2008-11-29
End date: 2008-12-25
Urbanyl
Dosage: unk
Indication: Epilepsy
Start date: 2008-12-15
Vancomycin HCL
Dosage: unk
Indication: Pneumonia Staphylococcal
Start date: 2008-12-01
Other drugs received by patient: Duphalac; Neostigmine Bromide; Aciclovir; Neupogen; Norepinephrine Bitartrate; Claforan; Solu-Medrol; Paracetamol
Possible Depakene side effects in 42 year old male
Reported by a physician from Japan on 2012-01-05
Patient: 42 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Diarrhoea, Status Epilepticus, Apparent Life Threatening Event, Drug Rash With Eosinophilia and Systemic Symptoms, Disease Progression
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: po
Administration route: Oral
Indication: Epilepsy
Start date: 2006-11-11
Phenytoin
Dosage: indrp
Indication: Status Epilepticus
Start date: 2009-06-25
Tegretol
Dosage: po
Administration route: Oral
Indication: Status Epilepticus
Start date: 2009-06-25
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-11-28
End date: 2006-12-26
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-01-25
End date: 2009-05-18
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2009-09-28
End date: 2010-05-04
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2010-06-11
End date: 2010-10-05
Other drugs received by patient: Kytril / 01178102 /
Possible Depakene side effects in 20 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-04
Patient: 20 year old female
Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Drug Screen Positive, Nausea, Hepatic Failure, Prothrombin Time Prolonged, Headache, Hepatitis, Convulsion, Hepatic Steatosis, Haemoglobin Decreased, Diarrhoea, Hepatitis Fulminant, Cough, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: dose decreased
Start date: 2005-01-24
End date: 2005-02-04
Depakene
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2004-10-30
End date: 2005-01-23
Gestodene and Ethinyl Estradiol
Dosage: 1 unit daily
Administration route: Oral
Indication: Contraception
Start date: 2004-01-01
Urbanyl
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2004-10-30
End date: 2005-02-04
Other drugs received by patient: Gestodene and Ethinyl Estradiol
Possible Depakene side effects in 85 year old male
Reported by a physician from Poland on 2011-12-20
Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Death, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Abilify
Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Depakene
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Lamotrigine
Indication: Schizophrenia, Paranoid Type
Start date: 2011-11-03
End date: 2011-12-10
Possible Depakene side effects in 20 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-20
Patient: 20 year old female
Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Drug Screen Positive, Nausea, Hepatic Failure, Headache, Prothrombin Time Prolonged, Hepatitis, Convulsion, Hepatic Steatosis, Haemoglobin Decreased, Diarrhoea, Hepatitis Fulminant, Cough, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2004-10-30
End date: 2005-01-23
Depakene
Dosage: dose decreased
Start date: 2005-01-24
End date: 2005-02-04
Gestodene and Ethinyl Estradiol
Dosage: 1 unit daily
Administration route: Oral
Indication: Contraception
Start date: 2004-01-01
Urbanyl
Administration route: Oral
Indication: Myoclonic Epilepsy
Start date: 2004-10-30
End date: 2005-02-04
Other drugs received by patient: Gestodene and Ethinyl Estradiol
Possible Depakene side effects in 65 year old male
Reported by a physician from France on 2011-12-16
Patient: 65 year old male
Reactions: Disseminated Intravascular Coagulation, Cholestasis, Stevens-Johnson Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Epilepsy
End date: 2011-11-05
Lamictal
Administration route: Oral
Indication: Epilepsy
Start date: 2011-10-12
End date: 2011-11-05
Page 1 Next >>
|